Copyright
©The Author(s) 2023.
World J Gastrointest Oncol. May 15, 2023; 15(5): 810-827
Published online May 15, 2023. doi: 10.4251/wjgo.v15.i5.810
Published online May 15, 2023. doi: 10.4251/wjgo.v15.i5.810
Figure 4 Analyses of mouse choroidal endothelial sprouts in sprouting and regression models.
A: BZD9L1 impeded mouse choroidal endothelial sprouting 96 h post-treatment; B: Regressed choroid sprouting 24 h post-treatment compared to the negative control. A receptor like type 1 anti-angiogenic agent was used as the positive control regression and sprouting assays. Statistical analysis (aP < 0.05; cP < 0.001), one-way ANOVA with Bonferroni posthoc test, n = 2 independent experiments using GraphPad Prism 9.4.0. Error bars represent SEM. ALK1: A receptor like type 1; NC: Negative control.
- Citation: Oon CE, Subramaniam AV, Ooi LY, Yehya AHS, Lee YT, Kaur G, Sasidharan S, Qiu B, Wang X. BZD9L1 benzimidazole analogue hampers colorectal tumor progression by impeding angiogenesis. World J Gastrointest Oncol 2023; 15(5): 810-827
- URL: https://www.wjgnet.com/1948-5204/full/v15/i5/810.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v15.i5.810